Neonatal hyperbilirubinemia

Journal of Perinatal and Neonatal Nursing

Volumn 20, Issue 1, 2006, Pages 103-107

  Schwoebel, Ann ^a   Gennaro, Susan ^b  

^a PENNSYLVANIA HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hyperbilirubinemia; Kernicterus; Neonate; Systems approach

Indexed keywords

EVIDENCE BASED MEDICINE; EXCHANGE BLOOD TRANSFUSION; FORECASTING; HEALTH SERVICE; HUMAN; INCIDENCE; INFECTION CONTROL; KERNICTERUS; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN JAUNDICE; NEWBORN NURSING; NEWBORN SCREENING; NURSE ATTITUDE; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; PHOTOTHERAPY; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RISK FACTOR; TOTAL QUALITY MANAGEMENT; UNITED STATES;

DISEASE NOTIFICATION; EVIDENCE-BASED MEDICINE; EXCHANGE TRANSFUSION, WHOLE BLOOD; FORECASTING; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INCIDENCE; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; KERNICTERUS; NEONATAL NURSING; NEONATAL SCREENING; NURSE'S ROLE; NURSING ASSESSMENT; PHOTOTHERAPY; PRACTICE GUIDELINES; PREVALENCE; RISK FACTORS; TOTAL QUALITY MANAGEMENT; UNITED STATES;

EID: 33646105384     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005237-200601000-00030     Document Type: Review

References (22)

1. . Robertson WO, Almquist JR, Light IJ, et al. American Academy of Pediatrics, Provisional Committee for Quality Improvement. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics. 1994;94(4):558-565.
2. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;4:297-316. Available at: http://www.aap.org/ jaundiceguidelines.htm.
3. JCAHO: revised guidance to help prevent kernicterus. Sentinel Event Alert. 2004;31(31):1-2.
4. Centers for Disease Control and Prevention. Kernicterus in full-term infants - United States, 1994-1998. JAMA. 2001;286:299-300. Available at: http://www.cdc. gov/ncbddd/dd/kernres.htm.
5. Serious reportable events report. A Consensus Report: A National Framework for Healthcare Quality Measurement and Reporting: National Quality Forum. Available at: http://www.qualityforum.org/activities/ca_ archive.htm. Accessed July 11, 2005.
6. Brown AK, Johnson L. Loss of concern about jaundice and the reemergence of kernicterus in full-term infants in the era of managed care. In: Fanaroff AA, Klaus MH, eds. The Year Book of Neonatal and Perinatal Medicine. Philadelphia: Mosby Yearbook; 1996:xvii-xxviii.
7. Johnson LH, Brown AK, Bhutani VK. System-based approach to management of neonatal jaundice and prevention of Kernicterus. J Pediatr. 2002;140:397-386.
8. Bhutani VK, Johnson LH, Maisels MJ, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol. 2004; 24(10):650-662.
9. Newman TB, Maisels MJ. Bilirubin and brain damage: what do we do now? Pediatrics. 1989;83(6):1062-1065.
10. Newman TB, Maisels MJ. Does hyperbilirubinemia damage the brain of healthy full-term infants? Clin Perinatol. 1990;17(2):331-358.
11. Watchko JF, Oski FA. Bilirubin 20 mg/dL = vigintiphobia. Pediatrics. 1983;71(4):660-663.
12. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics. 1992;89(5, pt 1):809-818.
13. Bhutani VK, Rodriguez M, HCA Perinatal Safety Initiative Kernicterus Taskforce. Recent Epidemiologic Indices of Severe Hyperbilirubinernia and Kernicterus for a Diverse Multi-State Newborn Population in USA. Pediatric Research; 2005. Abstract.
14. Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics. 2003;111(6, pt 1):1303-1311.
15. Soorani-Lunsing I, Woltil H, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain? Pediatr Res. 2001; 50:701-705.
16. Hadders-Algra M, Huisjes HJ, Touwen BC. Perinatal correlates of major and minor neurological dysfunction at school age: a multivariate analysis. Dev Med Child Neurol. 1988;30(4):472-481.
17. Hansen TW. Mechanisms of bilirubin toxicity: clinical implications. Clin Perinatol. 2002;29(4):765-778, viii.
18. Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyperbilirubinemia in the era of genomics. Semin Neonatol. 2002;7(2):143-152.
19. Palmer RH, Clanton M, Ezhuthachan S, et al. Applying the "10 simple rules" of the institute of medicine to management of hyperbilirubinemia in newborns. Pediatrics. 2003;112:1388-1393.
20. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a pre-discharge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103(1):6-14.
21. Schyve PM. Microsystems, macrosystems, and kernicterus. Jt Comm J Qual Saf. 2004;30(11):591-592.
22. Ip S, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114:e130-e153.